Eisai Ltd

European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire, AL10 9SN
Telephone: +44 (0)845 676 1400
Fax: +44 (0)845 676 1486
WWW: http://www.eisai.co.uk
Medical Information e-mail: Lmedinfo@eisai.net
Out of Hours Telephone: +44 (0)845 676 1400

Patient Information Leaflet last updated on the eMC: 20/01/2012
PIL Inovelon Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 02/12/2011 and displayed until 20/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 29/03/2011 and displayed until 02/12/2011
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 15/12/2009 and displayed until 29/03/2011
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 02/09/2009 and displayed until 15/12/2009
Reasons for adding or updating:
  • Change to Further Information section
Updated on 30/03/2009 and displayed until 02/09/2009
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
Updated on 30/06/2008 and displayed until 30/03/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 25/02/2008 and displayed until 30/06/2008
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
  • Change to date of revision
Updated on 26/09/2007 and displayed until 25/02/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   rufinamide